Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death

Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2004-07, Vol.170 (2), p.181-187
Hauptverfasser: Khalifah, Anthony P, Hachem, Ramsey R, Chakinala, Murali M, Schechtman, Kenneth B, Patterson, G. Alexander, Schuster, Daniel P, Mohanakumar, Thalachallour, Trulock, Elbert P, Walter, Michael J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 187
container_issue 2
container_start_page 181
container_title American journal of respiratory and critical care medicine
container_volume 170
creator Khalifah, Anthony P
Hachem, Ramsey R
Chakinala, Murali M
Schechtman, Kenneth B
Patterson, G. Alexander
Schuster, Daniel P
Mohanakumar, Thalachallour
Trulock, Elbert P
Walter, Michael J
description Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. The demographic and clinical characteristics of this population were analyzed for an association between BOS or death and potential risk factors, including community-acquired respiratory viral (CARV) infections, acute rejection, and cytomegalovirus pneumonitis. Respiratory syncytial virus, parainfluenza, influenza, and adenovirus accounted for 21 CARV infections. Univariate and multivariate time-dependent Cox regression analyses demonstrated that this CARV group was more likely to develop BOS, death, and death from BOS. Furthermore, these trends were more pronounced in patients with evidence of lower respiratory tract-CARV (lower-CARV) infections. Notably, the CARV and lower-CARV infections were risk factors for BOS, death, and death from BOS distinct from the risk attributable to acute rejection. Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post-CARV BOS.
doi_str_mv 10.1164/rccm.200310-1359OC
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66685839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66685839</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-f46f6c0883bab9683206404f202a679777011af2f3ee9430298d2017b7f16f153</originalsourceid><addsrcrecordid>eNqFkUuLFDEUhQtRnHH0D7iQICi4qPHeJJ3HcuzxMTDQMD5wF1PpxE5bVWmTaqT_vWmqQXHj6t7Fd87l3NM0TxEuEQV_nZ0bLikAQ2iRLfRqea85xwVbtFxLuF93kKzlXH89ax6VsgVAqhAeNme4QAYa1Hnz7c6XXcx2SvlAvtSlJzdj8G6KaSzkKntiyXUsUxzdRO5i-UFCyuRNTqPbxNTHKRay6ur02VbBx8O4zmmoqnFNrr2dNo-bB8H2xT85zYvm87u3n5Yf2tvV-5vl1W3rOMWpDVwE4UAp1tlOC8UoCA48UKBWSC2lBEQbaGDea86AarWmgLKTAUWooS-al7PvLqefe18mM8TifN_b0ad9MUIItVBM_xdEVc25ohV8_g-4Tfs81hAGtRacM6kqRGfI5VRK9sHschxsPhgEc2zJHFsyc0tmbqmKnp2c993g138kp1oq8OIE2OJsH-pvXSx_cZpRxkTlXs3cJn7f_IrZmzLYvq-2aOz2eBklGFozIfsNQ86n2g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199644378</pqid></control><display><type>article</type><title>Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Khalifah, Anthony P ; Hachem, Ramsey R ; Chakinala, Murali M ; Schechtman, Kenneth B ; Patterson, G. Alexander ; Schuster, Daniel P ; Mohanakumar, Thalachallour ; Trulock, Elbert P ; Walter, Michael J</creator><creatorcontrib>Khalifah, Anthony P ; Hachem, Ramsey R ; Chakinala, Murali M ; Schechtman, Kenneth B ; Patterson, G. Alexander ; Schuster, Daniel P ; Mohanakumar, Thalachallour ; Trulock, Elbert P ; Walter, Michael J</creatorcontrib><description>Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. The demographic and clinical characteristics of this population were analyzed for an association between BOS or death and potential risk factors, including community-acquired respiratory viral (CARV) infections, acute rejection, and cytomegalovirus pneumonitis. Respiratory syncytial virus, parainfluenza, influenza, and adenovirus accounted for 21 CARV infections. Univariate and multivariate time-dependent Cox regression analyses demonstrated that this CARV group was more likely to develop BOS, death, and death from BOS. Furthermore, these trends were more pronounced in patients with evidence of lower respiratory tract-CARV (lower-CARV) infections. Notably, the CARV and lower-CARV infections were risk factors for BOS, death, and death from BOS distinct from the risk attributable to acute rejection. Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post-CARV BOS.</description><identifier>ISSN: 1073-449X</identifier><identifier>ISSN: 0003-0805</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200310-1359OC</identifier><identifier>PMID: 15130908</identifier><language>eng</language><publisher>New York, NY: Am Thoracic Soc</publisher><subject>Adenovirus ; Adenoviruses ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Bronchiolitis Obliterans - epidemiology ; Bronchoscopy ; Cohort analysis ; Cohort Studies ; Community-Acquired Infections - epidemiology ; Comorbidity ; Cytomegalovirus ; Female ; Graft Rejection - epidemiology ; Humans ; Infections ; Influenza ; Intensive care medicine ; Lung Transplantation - statistics &amp; numerical data ; Lung transplants ; Male ; Medical records ; Medical sciences ; Middle Aged ; Missouri - epidemiology ; Mortality ; Multivariate Analysis ; Pathogenesis ; Pediatrics ; Respiratory syncytial virus ; Respiratory Tract Infections - epidemiology ; Retrospective Studies ; Risk Factors ; Survival Analysis ; Viral infections ; Virus Diseases - epidemiology</subject><ispartof>American journal of respiratory and critical care medicine, 2004-07, Vol.170 (2), p.181-187</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright American Thoracic Society Jul 15, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-f46f6c0883bab9683206404f202a679777011af2f3ee9430298d2017b7f16f153</citedby><cites>FETCH-LOGICAL-c421t-f46f6c0883bab9683206404f202a679777011af2f3ee9430298d2017b7f16f153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4011,4012,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15932336$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15130908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khalifah, Anthony P</creatorcontrib><creatorcontrib>Hachem, Ramsey R</creatorcontrib><creatorcontrib>Chakinala, Murali M</creatorcontrib><creatorcontrib>Schechtman, Kenneth B</creatorcontrib><creatorcontrib>Patterson, G. Alexander</creatorcontrib><creatorcontrib>Schuster, Daniel P</creatorcontrib><creatorcontrib>Mohanakumar, Thalachallour</creatorcontrib><creatorcontrib>Trulock, Elbert P</creatorcontrib><creatorcontrib>Walter, Michael J</creatorcontrib><title>Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. The demographic and clinical characteristics of this population were analyzed for an association between BOS or death and potential risk factors, including community-acquired respiratory viral (CARV) infections, acute rejection, and cytomegalovirus pneumonitis. Respiratory syncytial virus, parainfluenza, influenza, and adenovirus accounted for 21 CARV infections. Univariate and multivariate time-dependent Cox regression analyses demonstrated that this CARV group was more likely to develop BOS, death, and death from BOS. Furthermore, these trends were more pronounced in patients with evidence of lower respiratory tract-CARV (lower-CARV) infections. Notably, the CARV and lower-CARV infections were risk factors for BOS, death, and death from BOS distinct from the risk attributable to acute rejection. Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post-CARV BOS.</description><subject>Adenovirus</subject><subject>Adenoviruses</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Bronchiolitis Obliterans - epidemiology</subject><subject>Bronchoscopy</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Comorbidity</subject><subject>Cytomegalovirus</subject><subject>Female</subject><subject>Graft Rejection - epidemiology</subject><subject>Humans</subject><subject>Infections</subject><subject>Influenza</subject><subject>Intensive care medicine</subject><subject>Lung Transplantation - statistics &amp; numerical data</subject><subject>Lung transplants</subject><subject>Male</subject><subject>Medical records</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Missouri - epidemiology</subject><subject>Mortality</subject><subject>Multivariate Analysis</subject><subject>Pathogenesis</subject><subject>Pediatrics</subject><subject>Respiratory syncytial virus</subject><subject>Respiratory Tract Infections - epidemiology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Survival Analysis</subject><subject>Viral infections</subject><subject>Virus Diseases - epidemiology</subject><issn>1073-449X</issn><issn>0003-0805</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkUuLFDEUhQtRnHH0D7iQICi4qPHeJJ3HcuzxMTDQMD5wF1PpxE5bVWmTaqT_vWmqQXHj6t7Fd87l3NM0TxEuEQV_nZ0bLikAQ2iRLfRqea85xwVbtFxLuF93kKzlXH89ax6VsgVAqhAeNme4QAYa1Hnz7c6XXcx2SvlAvtSlJzdj8G6KaSzkKntiyXUsUxzdRO5i-UFCyuRNTqPbxNTHKRay6ur02VbBx8O4zmmoqnFNrr2dNo-bB8H2xT85zYvm87u3n5Yf2tvV-5vl1W3rOMWpDVwE4UAp1tlOC8UoCA48UKBWSC2lBEQbaGDea86AarWmgLKTAUWooS-al7PvLqefe18mM8TifN_b0ad9MUIItVBM_xdEVc25ohV8_g-4Tfs81hAGtRacM6kqRGfI5VRK9sHschxsPhgEc2zJHFsyc0tmbqmKnp2c993g138kp1oq8OIE2OJsH-pvXSx_cZpRxkTlXs3cJn7f_IrZmzLYvq-2aOz2eBklGFozIfsNQ86n2g</recordid><startdate>20040715</startdate><enddate>20040715</enddate><creator>Khalifah, Anthony P</creator><creator>Hachem, Ramsey R</creator><creator>Chakinala, Murali M</creator><creator>Schechtman, Kenneth B</creator><creator>Patterson, G. Alexander</creator><creator>Schuster, Daniel P</creator><creator>Mohanakumar, Thalachallour</creator><creator>Trulock, Elbert P</creator><creator>Walter, Michael J</creator><general>Am Thoracic Soc</general><general>American Lung Association</general><general>American Thoracic Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20040715</creationdate><title>Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death</title><author>Khalifah, Anthony P ; Hachem, Ramsey R ; Chakinala, Murali M ; Schechtman, Kenneth B ; Patterson, G. Alexander ; Schuster, Daniel P ; Mohanakumar, Thalachallour ; Trulock, Elbert P ; Walter, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-f46f6c0883bab9683206404f202a679777011af2f3ee9430298d2017b7f16f153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenovirus</topic><topic>Adenoviruses</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Bronchiolitis Obliterans - epidemiology</topic><topic>Bronchoscopy</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Comorbidity</topic><topic>Cytomegalovirus</topic><topic>Female</topic><topic>Graft Rejection - epidemiology</topic><topic>Humans</topic><topic>Infections</topic><topic>Influenza</topic><topic>Intensive care medicine</topic><topic>Lung Transplantation - statistics &amp; numerical data</topic><topic>Lung transplants</topic><topic>Male</topic><topic>Medical records</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Missouri - epidemiology</topic><topic>Mortality</topic><topic>Multivariate Analysis</topic><topic>Pathogenesis</topic><topic>Pediatrics</topic><topic>Respiratory syncytial virus</topic><topic>Respiratory Tract Infections - epidemiology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Survival Analysis</topic><topic>Viral infections</topic><topic>Virus Diseases - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khalifah, Anthony P</creatorcontrib><creatorcontrib>Hachem, Ramsey R</creatorcontrib><creatorcontrib>Chakinala, Murali M</creatorcontrib><creatorcontrib>Schechtman, Kenneth B</creatorcontrib><creatorcontrib>Patterson, G. Alexander</creatorcontrib><creatorcontrib>Schuster, Daniel P</creatorcontrib><creatorcontrib>Mohanakumar, Thalachallour</creatorcontrib><creatorcontrib>Trulock, Elbert P</creatorcontrib><creatorcontrib>Walter, Michael J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khalifah, Anthony P</au><au>Hachem, Ramsey R</au><au>Chakinala, Murali M</au><au>Schechtman, Kenneth B</au><au>Patterson, G. Alexander</au><au>Schuster, Daniel P</au><au>Mohanakumar, Thalachallour</au><au>Trulock, Elbert P</au><au>Walter, Michael J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2004-07-15</date><risdate>2004</risdate><volume>170</volume><issue>2</issue><spage>181</spage><epage>187</epage><pages>181-187</pages><issn>1073-449X</issn><issn>0003-0805</issn><eissn>1535-4970</eissn><abstract>Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. The demographic and clinical characteristics of this population were analyzed for an association between BOS or death and potential risk factors, including community-acquired respiratory viral (CARV) infections, acute rejection, and cytomegalovirus pneumonitis. Respiratory syncytial virus, parainfluenza, influenza, and adenovirus accounted for 21 CARV infections. Univariate and multivariate time-dependent Cox regression analyses demonstrated that this CARV group was more likely to develop BOS, death, and death from BOS. Furthermore, these trends were more pronounced in patients with evidence of lower respiratory tract-CARV (lower-CARV) infections. Notably, the CARV and lower-CARV infections were risk factors for BOS, death, and death from BOS distinct from the risk attributable to acute rejection. Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post-CARV BOS.</abstract><cop>New York, NY</cop><pub>Am Thoracic Soc</pub><pmid>15130908</pmid><doi>10.1164/rccm.200310-1359OC</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2004-07, Vol.170 (2), p.181-187
issn 1073-449X
0003-0805
1535-4970
language eng
recordid cdi_proquest_miscellaneous_66685839
source MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Adenovirus
Adenoviruses
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bronchiolitis Obliterans - epidemiology
Bronchoscopy
Cohort analysis
Cohort Studies
Community-Acquired Infections - epidemiology
Comorbidity
Cytomegalovirus
Female
Graft Rejection - epidemiology
Humans
Infections
Influenza
Intensive care medicine
Lung Transplantation - statistics & numerical data
Lung transplants
Male
Medical records
Medical sciences
Middle Aged
Missouri - epidemiology
Mortality
Multivariate Analysis
Pathogenesis
Pediatrics
Respiratory syncytial virus
Respiratory Tract Infections - epidemiology
Retrospective Studies
Risk Factors
Survival Analysis
Viral infections
Virus Diseases - epidemiology
title Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T20%3A26%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Respiratory%20Viral%20Infections%20Are%20a%20Distinct%20Risk%20for%20Bronchiolitis%20Obliterans%20Syndrome%20and%20Death&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Khalifah,%20Anthony%20P&rft.date=2004-07-15&rft.volume=170&rft.issue=2&rft.spage=181&rft.epage=187&rft.pages=181-187&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200310-1359OC&rft_dat=%3Cproquest_cross%3E66685839%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199644378&rft_id=info:pmid/15130908&rfr_iscdi=true